ASX - Delayed Quote AUD

The Hydration Pharmaceuticals Company Limited (HPC.AX)

0.0100
0.0000
(0.00%)
At close: 10:04:17 AM GMT+10
Loading Chart for HPC.AX
  • Previous Close 0.0100
  • Open 0.0100
  • Bid 0.0090 x --
  • Ask 0.0100 x --
  • Day's Range 0.0100 - 0.0100
  • 52 Week Range 0.0070 - 0.0350
  • Volume 36,669
  • Avg. Volume 295,553
  • Market Cap (intraday) 3.833M
  • Beta (5Y Monthly) 0.99
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. The company sells its products under the Hydralyte brand through retail stores and online. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is based in Melbourne, Australia.

hydralyte.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HPC.AX

View More

Performance Overview: HPC.AX

Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

HPC.AX
44.44%
S&P/ASX 200 [XJO] (^AXJO)
2.26%

1-Year Return

HPC.AX
23.08%
S&P/ASX 200 [XJO] (^AXJO)
6.10%

3-Year Return

HPC.AX
95.70%
S&P/ASX 200 [XJO] (^AXJO)
16.76%

5-Year Return

HPC.AX
96.67%
S&P/ASX 200 [XJO] (^AXJO)
49.71%

Compare To: HPC.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HPC.AX

View More

Valuation Measures

Annual
As of 5/20/2025
  • Market Cap

    3.83M

  • Enterprise Value

    7.85M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.58

  • Price/Book (mrq)

    0.90

  • Enterprise Value/Revenue

    1.57

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    83.23%

  • Return on Assets (ttm)

    -44.88%

  • Return on Equity (ttm)

    -476.06%

  • Revenue (ttm)

    3.2M

  • Net Income Avi to Common (ttm)

    -5.67M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.22M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.18M

Research Analysis: HPC.AX

View More

Company Insights: HPC.AX

Research Reports: HPC.AX

View More

People Also Watch